Pharma associations in agreement on medical representatives in China

A group of four pharma industry associations have signed a memorandum of understanding in China to adopt pro-medicine and patient-centered principles, build public consensus on the value of medical representatives and establish a national system to manage them, and promote proper and orderly development of the sector.

This agreement was signed at the 2016 Pharmaceutical Enterprises Ethical Business Practices China Forum in Beijing.

The aim of the forum was to further implement the Pharmaceutical Enterprise Ethical Business Practice, an initiative backed by the sector and government which is aimed at enhancing industry self-discipline and standardizing communication between medical institutions and pharmaceutical enterprises.